-
1
-
-
0001122821
-
Polymorphisms of the platelet glycoprotein (GP) Iba kozak sequence determines the surface level of the GP-1b-IX-V complex and risk for early myocardial infarction
-
Afshar-Kharghan V., Khoshnevis-Asl M., Hopkins P., Lopez J.A. Polymorphisms of the platelet glycoprotein (GP) Iba kozak sequence determines the surface level of the GP-1b-IX-V complex and risk for early myocardial infarction. Blood. 92:1998;A2887.
-
(1998)
Blood
, vol.92
, pp. 2887
-
-
Afshar-Kharghan, V.1
Khoshnevis-Asl, M.2
Hopkins, P.3
Lopez, J.A.4
-
2
-
-
0027314843
-
Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of US adults
-
Anda R., Williamson D., Jones D., Macera C., Eaker E., Glassman A., Marks J. Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of US adults. Epidemiology. 4:1993;285-294.
-
(1993)
Epidemiology
, vol.4
, pp. 285-294
-
-
Anda, R.1
Williamson, D.2
Jones, D.3
Macera, C.4
Eaker, E.5
Glassman, A.6
Marks, J.7
-
3
-
-
0027281068
-
Major depression in stroke patients: A 3-year longitudinal study
-
Astrom M., Adolfsson R., Asplund K. Major depression in stroke patients: a 3-year longitudinal study. Stroke. 24:1993;976-982.
-
(1993)
Stroke
, vol.24
, pp. 976-982
-
-
Astrom, M.1
Adolfsson, R.2
Asplund, K.3
-
4
-
-
0029990528
-
Symptoms of depression, acute myocardial infarction, and total mortality in a community sample
-
Barefoot J.C., Schroll M. Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. Circulation. 93:1996;1976-1980.
-
(1996)
Circulation
, vol.93
, pp. 1976-1980
-
-
Barefoot, J.C.1
Schroll, M.2
-
5
-
-
0020398347
-
Physiological and psychological variables predict compliance to prescribed exercise therapy in patients recovering from myocardial infarction
-
Blumenthal J.A., Williams R.S., Wallace A.G., Williams R.B. Jr., Needles T.L. Physiological and psychological variables predict compliance to prescribed exercise therapy in patients recovering from myocardial infarction. Psychosomatic Medicine. 44:1982;519-529.
-
(1982)
Psychosomatic Medicine
, vol.44
, pp. 519-529
-
-
Blumenthal, J.A.1
Williams, R.S.2
Wallace, A.G.3
Williams R.B., Jr.4
Needles, T.L.5
-
6
-
-
0029201969
-
Major depression and medication adherence in elderly patients with coronary artery disease
-
Carney R.M., Freedland K.E., Eisen S.A., Rich M.W., Jaffe A.S. Major depression and medication adherence in elderly patients with coronary artery disease. Health Psychology. 14:1995;88-90.
-
(1995)
Health Psychology
, vol.14
, pp. 88-90
-
-
Carney, R.M.1
Freedland, K.E.2
Eisen, S.A.3
Rich, M.W.4
Jaffe, A.S.5
-
7
-
-
0034061810
-
Changes in glycoprotein expression after platelet activation: Differences between in vitro and in vivo studies
-
Escolar G., White J.G. Changes in glycoprotein expression after platelet activation: differences between in vitro and in vivo studies. Thrombosis and Haemostasis. 83:2000;371-386.
-
(2000)
Thrombosis and Haemostasis
, vol.83
, pp. 371-386
-
-
Escolar, G.1
White, J.G.2
-
9
-
-
0025847505
-
Subcortical hyperintensities on brain magnetic resonance imaging: A comparison between late age onset and early onset elderly depressed subjects
-
Figiel G.S., Krishnan K.R.R., Doraiswamy P.M., Rao V.P., Nemeroff C.B., Boyko O.B. Subcortical hyperintensities on brain magnetic resonance imaging: a comparison between late age onset and early onset elderly depressed subjects. Neurobiology and Aging. 26:1991;245-247.
-
(1991)
Neurobiology and Aging
, vol.26
, pp. 245-247
-
-
Figiel, G.S.1
Krishnan, K.R.R.2
Doraiswamy, P.M.3
Rao, V.P.4
Nemeroff, C.B.5
Boyko, O.B.6
-
11
-
-
0027435361
-
Incidence of silent cerebral infarction in patients with major depression
-
Fujikawa T., Yamawaki S., Touhouda Y. Incidence of silent cerebral infarction in patients with major depression. Stroke. 24:1993;1631-1634.
-
(1993)
Stroke
, vol.24
, pp. 1631-1634
-
-
Fujikawa, T.1
Yamawaki, S.2
Touhouda, Y.3
-
13
-
-
0031804581
-
The high cost of stroke to society, the family, and the patient
-
Horner R.D. The high cost of stroke to society, the family, and the patient. Pharmacotherapy. 18:1998;87-93.
-
(1998)
Pharmacotherapy
, vol.18
, pp. 87-93
-
-
Horner, R.D.1
-
14
-
-
0034745237
-
Mortality at 12 and 24 months after stroke may be associated with depressive symptoms at 1 month
-
House A., Knapp P., Bamford J., Vail A. Mortality at 12 and 24 months after stroke may be associated with depressive symptoms at 1 month. Stroke. 32:2001;696-701.
-
(2001)
Stroke
, vol.32
, pp. 696-701
-
-
House, A.1
Knapp, P.2
Bamford, J.3
Vail, A.4
-
15
-
-
0033862347
-
Symptoms of depression as a prospective risk factor for stroke
-
Jonas B.S., Mussolino M.E. Symptoms of depression as a prospective risk factor for stroke. Psychosomatic Medicine. 62:2000;463-471.
-
(2000)
Psychosomatic Medicine
, vol.62
, pp. 463-471
-
-
Jonas, B.S.1
Mussolino, M.E.2
-
16
-
-
0035984998
-
Platelet glycoprotein Ib alpha receptor polymorphisms and recurrent ischaemic events in acute coronary syndrome patients
-
Kenny D., Muckian C., Fitzgerald D.J., Cannon C.P., Shields D.C. Platelet glycoprotein Ib alpha receptor polymorphisms and recurrent ischaemic events in acute coronary syndrome patients. J Thromb Thrombolysis. 13:2002;13-19.
-
(2002)
J Thromb Thrombolysis
, vol.13
, pp. 13-19
-
-
Kenny, D.1
Muckian, C.2
Fitzgerald, D.J.3
Cannon, C.P.4
Shields, D.C.5
-
17
-
-
0028798992
-
Shear-induced platelet aggregation in normal subjects and stroke patients
-
Konstantopoulos K., Grotta J.C., Sills C., Wu K.K., Hellums J.D. Shear-induced platelet aggregation in normal subjects and stroke patients. Thrombosis and Haemostasis. 74:1995;1329-1334.
-
(1995)
Thrombosis and Haemostasis
, vol.74
, pp. 1329-1334
-
-
Konstantopoulos, K.1
Grotta, J.C.2
Sills, C.3
Wu, K.K.4
Hellums, J.D.5
-
18
-
-
0030847087
-
Elevated platelet factor 4 and β-thromboglobulin plasma levels in depressed patients with ischemic heart disease
-
Laghrissi-Thode F., Wagner W.R., Pollock B.G., Johnson P.C., Finkel M.S. Elevated platelet factor 4 and β-thromboglobulin plasma levels in depressed patients with ischemic heart disease. Biological Psychiatry. 42:1997;290-295.
-
(1997)
Biological Psychiatry
, vol.42
, pp. 290-295
-
-
Laghrissi-Thode, F.1
Wagner, W.R.2
Pollock, B.G.3
Johnson, P.C.4
Finkel, M.S.5
-
19
-
-
0035943139
-
Increased platelet aggregability in major depression?
-
Lederbogen F., Gilles M., Maras A., Hamann B., Colla M., Heuser I., Deuschle M. Increased platelet aggregability in major depression? Psychiatry Research. 102:2001;255-261.
-
(2001)
Psychiatry Research
, vol.102
, pp. 255-261
-
-
Lederbogen, F.1
Gilles, M.2
Maras, A.3
Hamann, B.4
Colla, M.5
Heuser, I.6
Deuschle, M.7
-
20
-
-
0029062761
-
Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine
-
Lefkovits J., Plow E.F., Topol E.J. Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine. New England Journal of Medicine. 332:1995;1553-1559.
-
(1995)
New England Journal of Medicine
, vol.332
, pp. 1553-1559
-
-
Lefkovits, J.1
Plow, E.F.2
Topol, E.J.3
-
21
-
-
0025789881
-
Platelets and coronary heart disease: Potential pathophysiological mechanisms
-
Markowitz J.H., Matthews K.A. Platelets and coronary heart disease: potential pathophysiological mechanisms. Psychosomatic Medicine. 53:1991;643-668.
-
(1991)
Psychosomatic Medicine
, vol.53
, pp. 643-668
-
-
Markowitz, J.H.1
Matthews, K.A.2
-
22
-
-
0034125861
-
Platelet activation in depression and effects of sertraline treatment: An open label study
-
Markowitz J.H., Shuster J.L., Chitwood W.S., May R.S., Tolbert L.C. Platelet activation in depression and effects of sertraline treatment: an open label study. American Journal of Psychiatry. 157:2000;1006-1008.
-
(2000)
American Journal of Psychiatry
, vol.157
, pp. 1006-1008
-
-
Markowitz, J.H.1
Shuster, J.L.2
Chitwood, W.S.3
May, R.S.4
Tolbert, L.C.5
-
23
-
-
0034429879
-
Evaluation of platelet function by flow cytometry
-
Michelson A.D., Barnard M.R., Krueger L.A., Frelinger A.L. III, Furman M.I. Evaluation of platelet function by flow cytometry. Methods. 21:2000;259-270.
-
(2000)
Methods
, vol.21
, pp. 259-270
-
-
Michelson, A.D.1
Barnard, M.R.2
Krueger, L.A.3
Frelinger A.L. III4
Furman, M.I.5
-
25
-
-
0027509882
-
Association of depression with 10-year poststroke mortality
-
Morris P.L., Robinson R.G., Andrzejewski P., Samuels J., Price T.R. Association of depression with 10-year poststroke mortality. American Journal of Psychiatry. 150:1993;124-129.
-
(1993)
American Journal of Psychiatry
, vol.150
, pp. 124-129
-
-
Morris, P.L.1
Robinson, R.G.2
Andrzejewski, P.3
Samuels, J.4
Price, T.R.5
-
26
-
-
0033857466
-
Platelet reactivity in depressed patients treated with paroxetine
-
Musselman D.L., Marzec U.M., Manatunga A., Penna S., Reemsnyder A., Knight B.T., Baron A., Hanson S.R., Nemeroff C.B. Platelet reactivity in depressed patients treated with paroxetine. Archives in General Psychiatry. 57:2000;875-882.
-
(2000)
Archives in General Psychiatry
, vol.57
, pp. 875-882
-
-
Musselman, D.L.1
Marzec, U.M.2
Manatunga, A.3
Penna, S.4
Reemsnyder, A.5
Knight, B.T.6
Baron, A.7
Hanson, S.R.8
Nemeroff, C.B.9
-
27
-
-
0029786527
-
Exaggerated platelet reactivity in major depression
-
Musselman D.L., Tomer A., Manatunga A.K., Knight, Porter M.R., Kasey S., Marzec U., Harker L.A., Nemeroff C.B. Exaggerated platelet reactivity in major depression. American Journal of Psychiatry. 153:1996;1313-1317.
-
(1996)
American Journal of Psychiatry
, vol.153
, pp. 1313-1317
-
-
Musselman, D.L.1
Tomer, A.2
Manatunga, A.K.3
Knight4
Porter, M.R.5
Kasey, S.6
Marzec, U.7
Harker, L.A.8
Nemeroff, C.B.9
-
28
-
-
0025253308
-
Enhanced botrocetin-induced type IIB von Willebrand factor binding to platelet glycoprotein Ib initiates hyperagglutination of normal platelets
-
Nishio K., Fujimura Y., Niinomi K., Takahashi Y., Yoshioka A., Fukui H., Usami Y., Titani K., Ruggeri Z.M., Zimmerman T.S. Enhanced botrocetin-induced type IIB von Willebrand factor binding to platelet glycoprotein Ib initiates hyperagglutination of normal platelets. American Journal of Haematology. 33:1990;261-266.
-
(1990)
American Journal of Haematology
, vol.33
, pp. 261-266
-
-
Nishio, K.1
Fujimura, Y.2
Niinomi, K.3
Takahashi, Y.4
Yoshioka, A.5
Fukui, H.6
Usami, Y.7
Titani, K.8
Ruggeri, Z.M.9
Zimmerman, T.S.10
-
29
-
-
0025310669
-
The impact of poststroke depression on recovery in activities of daily living over a 2-year follow-up
-
Parikh R.M., Robinson R.G., Lipsey J.R., Starkstein S.E., Fedoroff J.P., Price T.R. The impact of poststroke depression on recovery in activities of daily living over a 2-year follow-up. Archives of Neurology. 47:1990;785-789.
-
(1990)
Archives of Neurology
, vol.47
, pp. 785-789
-
-
Parikh, R.M.1
Robinson, R.G.2
Lipsey, J.R.3
Starkstein, S.E.4
Fedoroff, J.P.5
Price, T.R.6
-
30
-
-
0034110584
-
Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment
-
Pollock B.G., Laghrissi-Thode F., Wagner W.R. Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment. Journal of Clinical Psychopharmacology. 20:2000;137-140.
-
(2000)
Journal of Clinical Psychopharmacology
, vol.20
, pp. 137-140
-
-
Pollock, B.G.1
Laghrissi-Thode, F.2
Wagner, W.R.3
-
32
-
-
0031837204
-
Risk factors for ischemic stroke: Dubbo study of the elderly
-
Simons L.A., McCallum J., Friedlander Y., Simons J. Risk factors for ischemic stroke: Dubbo study of the elderly. Stroke. 29:1998;1341-1346.
-
(1998)
Stroke
, vol.29
, pp. 1341-1346
-
-
Simons, L.A.1
McCallum, J.2
Friedlander, Y.3
Simons, J.4
-
34
-
-
0037123720
-
Depression is associated with an increase in the expression of the platelet adhesion receptor glycoprotein Ib
-
Walsh M.T., Dinan T.G., Condren R.M., Ryan M., Kenny D. Depression is associated with an increase in the expression of the platelet adhesion receptor glycoprotein Ib. Life Sciences. 70:(26):2002;3155-3165.
-
(2002)
Life Sciences
, vol.70
, Issue.26
, pp. 3155-3165
-
-
Walsh, M.T.1
Dinan, T.G.2
Condren, R.M.3
Ryan, M.4
Kenny, D.5
-
35
-
-
0033712603
-
Antiplatelet agents in stroke prevention. Combination therapy: Present and future
-
Weksler B.B. Antiplatelet agents in stroke prevention. Combination therapy: present and future. Cerebrovascular Disease. 10:(Supplement S5):2000;41-48.
-
(2000)
Cerebrovascular Disease
, vol.10
, Issue.SUPPL. S5
, pp. 41-48
-
-
Weksler, B.B.1
|